Skip to main content
Premium Trial:

Request an Annual Quote

Eurofins Genomics to Supply Oligonucleotides to Swedish Universities

NEW YORK (GenomeWeb) – Eurofins Genomics today announced it signed a two-year contract to be a preferred supplier of oligonucleotides to Lund University.

Eurofins Genomics becomes one of several preferred suppliers as part of a recently awarded framework contract, it said, adding the contract builds on long-standing relationship between the parties. Eurofins will now offer best oligonucleotide prices to Lund University, Gothenburg University, Linköping University, and Chalmers University of Technology.

"This contract will ensure that the whole scientist community in South Sweden will have access to the Eurofins Genomics' products and services and benefit from our commitment to them," Eurofins Genomics Senior VP Bruno Poddevin said in a statement.

In May the company inked a two-year contract with the UK Shared Business Services to be a preferred supplier of oligonucleotides and DNA sequencing.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.